Day: August 19, 2020

The MT Højgaard Group had a sound second quarter with rising order intake, a growing order book and improved earnings. Second-quarter EBIT was DKK 41 million, up from DKK 23 million in the second quarter of 2019, despite small effects from the Covid-19 crisis. First-half financial performance matched expectations, reaffirming the outlook of a gradual improvement in earnings during the year. The outlook for 2020 is unchanged.Summary of the first half of 2020 – MT Højgaard GroupFirst-half revenue was down 8% to DKK 2,881 million, as expected, mainly as a result of a temporary decline in activity at Enemærke & Petersen following low order intake in the first half of 2019.EBIT was DKK 44 million, up from DKK 41 million in the first half of 2019. The operating margin increased to 1.5% from 1.3% in the first half of 2019, reflecting an improved...

MT Højgaard-koncernen havde et fornuftigt 2. kvartal med et stigende ordreindgang, voksende ordrebeholdning og bedre driftsindtjening. Resultatet af primær drift (EBIT) blev 41 mio. kr. i 2. kvartal mod 23 mio. kr. i 2. kvartal 2019, trods mindre effekter af Covid-19 krisen. Resultaterne i 1. halvår var som ventet og bekræfter forventningen om en gradvis forbedring af indtjeningen igennem året. Forventningerne til 2020 er uændrede.Hovedpunkter i 1. halvår 2020 for MT Højgaard-koncernenOmsætningen i halvåret faldt som ventet 8% til 2.881 mio. kr. Faldet skyldes især midlertidig aktivitetsnedgang i Enemærke & Petersen efter et lavt ordreindtag i 1. halvår 2019.Det primære driftsresultat (EBIT) blev 44 mio. kr. mod 41 mio. kr. i 1. halvår 2019. På grund af bedre bruttomargin og lavere omkostninger steg driftsmarginen til 1,5% mod 1,3%...

København Ø, Aug. 19, 2020 (GLOBE NEWSWIRE) —Hermed indkaldes til ekstraordinær generalforsamling i Kapitalforeningen BankInvest, afdeling Small Cap Danske Aktier KL, den 7. september 2020.Dagsordenen kan ses af det vedhæftede dokument, som ligeledes kan downloades fra foreningens hjemmeside www.bankinvest.dk.Venlig hilsenBI Management A/SVedhæftet filIndkaldelse EGF Kap. BI Select, afd. Small Cap DK Akt 2020.09.07

ROAD TOWN, British Virgin Islands, Aug. 19, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (“Aura” or the “Company”) today provided an update on its exploration program at its Aranzazu Mining Complex located in Zacatecas, Mexico (“Aranzazu”).HighlightsExploration hole M-20-035 intersected 9.99 metres @ 1.70% Cu, 0.93 g/t Au and 17.57 g/t Ag (842.63 – 852.62m) including 3.50 metres @ 2.94% Cu, 2.21 g/t Au and 35.69 g/t Ag (849.12 – 852.62m) extending known inferred mineral resource at Glory Hole zone for further 220 meters downdip. Infill hole M-20-006 intersected 50.02 metres @ 6.46% Cu, 3.68 g/t Au and 95.21 g/t Ag (533.25 – 583.30m) including 34.30 metres @ 8.61% Cu, 4.88 g/t and 127.41 g/t Ag indicating significantly higher grade and thickness zone may be converted from inferred to measured and indicated mineral...

Borregaard ASA has issued a commercial paper ISIN NO0010891393 of NOK 200,000,000.Start date:                   21 August, 2020Maturity:                     21 February, 2021Coupon:                      0,71 %Organised by:              DNB MarketsSarpsborg, 19 August 2020Contact:CFO, Per Bjarne Lyngstad, mobile +47 952 44 515This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

BARRIE, Ontario, Aug. 19, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its Australian operation – MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) – has received an important enabling amendment to its Good Manufacturing Practice (“GMP”) Certification and Licence to Manufacture Therapeutic Goods.The licence expansion, granted under Section 40B of the Australian Therapeutic Goods Act 1989 by the Therapeutic Goods Administration of the Australian Government’s Department of Health, provides MediPharm Labs with the ability to manufacture Active Pharmaceutical Ingredient (“API”) derived from cannabis...

Announcement no. 20-202019 August 2020North Media continues to face an increased level of uncertainty from developments in and the consequences of the COVID-19 situation. However, the uncertainty is believed to be less severe now than it was on 18 March 2020 when it was decided as per announcement 12-2020 to suspend the recommendation for the payment of an ordinary dividend for the 2019 financial year.As a result, the Board of Directors resolved today to pay out the dividend of DKK 4.00 per share originally proposed. The total dividend to be distributed amounts to DKK 80.2 million, for a pay-out of DKK 71.8 million exclusive of the holding of treasury shares.The distribution is made as an extraordinary dividend on the basis of an interim balance sheet dated 30 June 2020 with an unqualified review report and no emphasis of matter by PricewaterhouseCoopers...

Selskabsmeddelelse nr. 20-202019. august 2020For North Media er der fortsat forhøjet usikkerhed forbundet med udviklingen i og konsekvenserne af COVID-19. Usikkerhederne vurderes imidlertid nu mindre end de var den 18. marts 2020, da det jf. selskabsmeddelelse nr. 12-2020 blev besluttet at suspendere indstillingen om udbetaling af et ordinært udbytte for regnskabsåret 2019.Derfor har bestyrelsen i dag besluttet at gennemføre udbetalingen af det oprindeligt foreslåede udbytte på 4,00 kr. pr. aktie. Samlet udloddes således 80,2 mio. kr., svarende til 71,8 mio. kr. eksklusive beholdningen af egne aktier.Udbyttet udbetales som et ekstraordinært udbytte på baggrund af en mellembalance pr. 30. juni 2020 med reviewerklæring uden forbehold og supplerende oplysninger fra PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.Udlodningen...